Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Taps NIH Veteran Corrigan-Curay To Lead Medical Policy Office

Executive Summary

Jennifer Corrigan-Curay joins from the National Heart, Lung and Blood Institute, where she worked on clinical trial initiatives and served as an NIH representative on FDA’s Drug Safety Oversight Board.


Related Content

Chief Scientist At US FDA Is Hinton As Borio Moves To White House
Merck R&D Exec Jumps To US FDA As Office Of New Drugs Deputy Director
Finally … Rachel Sherman Takes Califf's Old FDA Job
Off-Label Debate Between FDA, Industry To Formally Begin After Election
CDER Free Speech Response Complicated By Family Ties
FDA Drug Policy Office Reshuffled Over ‘Spousal Employment’ Conflict
The Look Of FDA’s Drug Safety Oversight Board





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts